Overview

Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia

Status:
Completed

Trial end date:
2010-01-01

Target enrollment:

Participant gender:

Summary

The objective of the study is to evaluate the efficacy of allopurinol, compared to placebo, as add-on to anti-psychotics in the treatment of patients with schizophrenia.

Phase:

Phase 4

Details

Lead Sponsor:

Sheba Medical Center

Treatments:

Allopurinol
Antipsychotic Agents